Because TAGLN is a TGF-β inducible gene that contributes to GDM-ECFC dysfunction19, we investigated whether nanoparticles loaded with SB-431542 and conjugated to the surface of ECFCs can stably normalize TAGLN expression. The gene discussed is TAGLN; the disease is gestational diabetes.